IMR — Imricor Medical Systems Cashflow Statement
0.000.00%
Last trade - 00:00- AU$613.65m
- AU$590.75m
- $0.29m
Annual cashflow statement for Imricor Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.7 | -17.4 | -22.6 | -29.7 | -25.3 |
| Depreciation | |||||
| Non-Cash Items | 1.94 | 1.11 | 6.89 | 14 | 5.34 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.389 | -0.978 | 1.9 | -0.77 | -0.101 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -17.5 | -16.5 | -13 | -15.6 | -19.1 |
| Capital Expenditures | -0.626 | -0.239 | -0.083 | -0.078 | -0.434 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.07 | 0 | — | 0.003 | -21.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.695 | -0.239 | -0.083 | -0.075 | -21.7 |
| Financing Cash Flow Items | — | -0.048 | -0.011 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.6 | 3.94 | 8.21 | 30.3 | 43 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.62 | -12.8 | -4.86 | 14.9 | 3.79 |